Cyril Salek

8PUBLICATIONS
36CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)Medical devicesMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 02, 2026
Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries.

|Apr 28, 2025
Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemia.

Jitka Krizkova, Vaclava Polivkova, Adam Laznicka

|Apr 09, 2025
NGS-MRD negativity in post-HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse risk.

Krystof Seferna, Michael Svaton, Andrea Rennerova

|Oct 17, 2024
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.

Patrice Chevallier, Thibaut Leguay, Marc Delord

|Mar 13, 2024
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.

Daniela Žáčková, Lukáš Semerád, Edgar Faber

|Feb 10, 2023
Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome.

Blanka Stiburkova, Katerina Pavelcova, Monika Belickova

Pageof 2

Frequent Collaborators

2 joint publications

Katerina Machova Polakova

1 joint publications

Blanka Stiburkova

1 joint publications

Monika Belickova

1 joint publications

Samuel J Magaziner